Book Value per Share: Ovid Rx (OVID)
Ovid Therapeutics Inc. develops unique molecules to combat epilepsy, leveraging patent protection. Its financial standing depends on liquidity reserves for conducting tests, while its growth trajectory is tied to the success of medical research. The final book value per share reflects changes in the capital structure, with 1.14 representing the current metric.
Ovid Therapeutics Inc - analytical breakdowns and key metrics (OVID)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:ovidrx.com, OVID
Net asset analysis is used to select assets with the maximum margin of safety, as net assets form an investor's liquidation cushion after deducting all liabilities. This criterion is critically important for Ovid Therapeutics Inc. (OVID) during a period of intensive R&D expenditures on epilepsy drugs, which is clearly reflected in the reported book value per share on the GURU.Markets platform.
Competitor analysis for Ovid Therapeutics Inc.
Book Value per Share BIIB (Biogen Corp)|NBIX - Net Assets per Share|Book Value per Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share PRAX (Praxis Precision Medicines)|Net Asset Value per Share anavex.com (AVXL)|Accounting Value per Share CeriBell (CBLL)|Net Assets per Single Share Prothena Corporation (PRTA)|Book Value per Share ALEC|Net Assets per Share Annexon Biosciences Inc. ANNX|Omeros Corp. (OMER) - Book Value per Share|neurogene.com (NGNE) - Equity per Share|Accounting Value per Share AC Immune SA ACIU|Accounting Value of a Share Voyager Therapeutics Inc|Neumora Therapeutics Inc (NMRA) - Accounting Value per Share|Book Price of a Share Scilex Holding Company, Inc.|Tevogen Bio Holdings (TVGN) - Book Value per Share|Accounting Value of a Share alphacognition.com (ACOG)|CGTX: Book Value per Share|Inhibikase Therapeutics Inc - Net Asset Value per Share|Net Assets per Single Share Cassava (SAVA)|ASRT - Accounting Value of a Share|COYA: Book Value per Share|VTGN (Vistagen) - Book Value per Share|Net Assets per Single Share Acumen Pharmaceuticals, Inc. ABOS|Share Book Value CervoMed, Inc.|Alterity Therapeutics - Book Value per Share|Net Asset Value per Share clene.com CLNN|Accounting Value per Share PEPG (PepGen)|JUNS - Book Value per Share|Accounting Value per Share Relmada Therapeutics, Inc. RLMD|ANVS - Book Price of a Share|gracetx.com - Book Value per Share|Firefly Neuro (AIFF) - Net Assets per Share|Book Value per Share KLTO|Accounting Value per Share NRSN|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Net Assets per Single Share|Net Assets per Share metaviatx.com MTVA|Accounting Value per Share NeurAxis, Inc|Accounting Value of a Share Helius Medical Technologies, Inc. HSDT|Book Value per Share PASG (Passage Bio Corp)|NEUP: Net Assets per Share|Net Assets per Single Share Minerva Neurosciences, Inc.|Athira Pharma Inc (ATHA) - Equity per Share|Book Value per Share ADXN|Accounting Value per Share Alzamend (ALZN)|CYCN (Cyclerion Therapeutics) - Accounting Value per Share|Net Assets per Share PTIX (protagenic.com)|KTTA: Net Assets per Single Share|CRGT - Net Asset Value per Share|ATXI - Accounting Value per Share|BCLI - Net Assets per Single Share|Cara Therapeutics, Inc. - Book Value per Share|chromocell.com (CHRO) - Net Assets per Share|Book Value per Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share ITCI|Net Assets per Single Share Longboard Pharma LBPH|Equity per Share Marinus Pharma (MRNS)|NKGN: Book Value per Share|NRBO - Net Asset Value per Share|Sage Therapeutics - Accounting Value per Share|SNPX: Book Value per Share|Net Assets per Single Share Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value of a Share|Net Assets per Single Share WENA (Anew Medical)|Net Asset Value per Share CERE